Liraglutide dose guide

Liraglutide dosage

The predecessor to semaglutide: a GLP-1 receptor agonist that reduces appetite and improves blood sugar control, given as a daily injection rather than weekly. Commonly reported: appetite drops and meals end sooner, though less dramatically than on semaglutide or tirzepatide, with nausea during the climb to 3 mg. FDA-approved for diabetes (Victoza) and obesity (Saxenda), with one of the longest track records of any GLP-1 drug.

Dose range

0.6–3 mg (fda label).

How often

Daily: Daily SubQ

A typical run

FDA-approved for daily use. Community uses continuously or until goal reached.

How it’s taken

Vial: SubQ injection

Evidence

Established: Clinical trials or FDA-approved use exists

Half-life

~13 hours

Liraglutide on your syringe

With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 1 mL (100-unit) U-100 insulin syringe: the low end, 0.6 mg, is 12 units; and the high end, 3 mg, is 60 units. 16 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.

Liraglutide in the peptide libraryThe Dose Guide: every peptide

More glp-1 & metabolic peptides

• Semaglutide 0.25–2.4 mg
• Semaglutide (oral) 1.5–25 mg
• Tirzepatide 2.5–15 mg
• Retatrutide 1–12 mg
• Dulaglutide 0.75–4.5 mg
• Orforglipron 0.8–17.2 mg
• Survodutide 0.3–6 mg
• Mazdutide 2–6 mg
• Pemvidutide 1.2–2.4 mg
• Cagrilintide 0.25–2.4 mg
• CagriSema 0.25–2.4 mg
• 5-Amino-1MQ 50–100 mg
• SLU-PP-332 250–1000 mcg
• Oxytocin 10–40 IU

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.